2Banerjee S, Varghese C, Samule J, et al. Comparison of the impact of short ( < 1 year) and long-term ( > or = 1 year) clopidogrel use following percutaneous coronary intervention on mortality[J]. Am J Cardiol,2008 ; 102(9) :1159-62.
3Roy P, Bonello L, Torguson R, et al. Temporal relation between clopi- dogrel cessation and stent thrombosis after drug-eluting stent implantation [J].Am J Cardiol,2009;103(6) :801-5.
4Park DW, Yun SC, Lee SW, et aL Stent thrombosis, clinical events, and influence of pro longed clopidogrel use after placement of drug-eluting stent : data from an observational cohort study of drug-eluting versus bare- metal stents[J].JACC Cardiovasc Interv ,2008 ; 1 ( 5 ) :494-503.
2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
3Singh SK, Suresh MV, Voleti B, et al. The connection between C-reactive protein and atherosclerosis[J]. Ann Med, 2008, 40(2 ):1 10-120.
4Donald M, Lloyd-jones. Narrative Review:Assessment of C- Reactive Protein in Risk Prediction for Cardiovascular Disease [J]. Ann Intern Med, 2006, 145( 1 ):35-42.
5Lee CH, Tan HC, Lim YT. Update on drug-eluting stents for prevention of restenosis [J]. Asian Cardiovasc Thorac Ann, 2006, 14 (1):75-82.
6Sub JW, Koo BK, Zhang SY, et al. Increased risk of atherothrombotic events associated with eytochrome P450 3A5 polymorphism in patients taking elopidogrel. CMAJ, 2006, 174(31): 1715-1722.
7Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogre:lareview of the evidence[J]. JAm Coil Cardiol, 2005, 45(9): 1157-1164.
8Eshaghima S, Kaul S, Amin S, et al. Role of clopidogrel in managing atherothrombotie cardiovascular disease [J]. Ann Intern Med, 2007, 146(6): 434-441.
9Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation[J]. Eur Heart J, 2006, 27(20 ):2420-2425.
10Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases:molecular mechanisms and clinical implications[J]. Circulation, 2006, 113(5):722-731.
